Prevention of experimentally induced gastric damage with the tripeptide ZAMI-420, a new thromboxane synthesis inhibitor.

Gervasi, G B; Fossati, A; Caliari, S; Rapalli, L; Bergamaschi, M

Gervasi, G B; Fossati, A; Caliari, S; Rapalli, L; Bergamaschi, M.

Int J Tissue React ; 5(3): 253-6, 1983.

Article in En | MEDLINE | ID: mdl-6418678

Subject(s)

Oligopeptides/pharmacology; Stomach/drug effects; Thromboxane A2/biosynthesis; Thromboxanes/biosynthesis; Animals; Arachidonic Acids/metabolism; Biological Assay; Carbenoxolone/pharmacology; Chromatography, Thin Layer; Cimetidine/pharmacology; Ethanol/adverse effects; Female; Guinea Pigs; Imidazoles/pharmacology; Platelet Aggregation/drug effects; Prostaglandin-Endoperoxide Synthases/metabolism; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains; Serotonin/adverse effects; Stomach Ulcer/chemically induced; Thromboxane A2/antagonists & inhibitors; Vasoconstriction/drug effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Oligopeptides / Stomach / Thromboxane A2 / Thromboxanes Limits: Animals Language: En Year: 1983 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Oligopeptides / Stomach / Thromboxane A2 / Thromboxanes Limits: Animals Language: En Year: 1983 Type: Article